XRCC5 and neoplasm: Ren and colleagues illuminated that miR-623 functioned as a tumor suppressor in hepatocellular carcinoma through modulating the phosphoinositide 3‐kinase/protein kinase B (PI3K/Akt) pathway via targeting X-ray repair cross complementing 5 (XRCC5) [27].